article thumbnail

Q&A: Physicians Weigh Improvements in MASLD Treatment Against Gaps in Assessment Strategies

Physician's Weekly

This is a well-done and concise summary of where we are in 2024 in trying to tackle the immense public health problem of MASLD.” In March 2024, resmetirom was the first treatment for noncirrhotic MASLD approved by the FDA, which is quite exciting. MASLD is the leading reason for referral to a hepatologist in many US medical centers.

article thumbnail

Orthopedic Pain Management: When to Skip the Specialist

Priority Physicians

An MRI augments and adds confidence to our clinical diagnosis. As you heal, check in with your direct primary care physician. See Your Direct Primary Care Doctor for Orthopedic Pain Management Are you concerned about swelling or recurring pain from a fall or sports injury? Is an MRI Always Needed?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Promise and Pitfalls of AI in Medicine: Guest Bob Wachter

GeriPal

And I wonder, now, was this 2024 version sort of a redo? And you say, “Okay, that’s fine, but can it really … What about a real live clinical situation?” And the actors were blinded to whether this was a primary care doctor or a chat bot answering them. That is the first clinical use case.

IT 139
article thumbnail

Not Only Harvard. RFK Jr.’s Slashed Science Funding Cuts Across States That Backed Trump

Physicians News Digest

including in most states that backed President Donald Trump in the 2024 election. Researchers whose funding was stripped said they stopped clinical trials and other work on improving care for people with HIV, reducing vaping and smoking rates among LGBTQ+ teens and young adults, and increasing vaccination rates for young children.